IV steroids for MS relapse: clinical governance implications

Area of Science:

• Neurology
• Healthcare Management
• Clinical Governance

Background:

• The UK's National Health Service (NHS) aims for increased patient choice and community-based care.
• Managing patients' health needs outside traditional hospital settings is becoming increasingly important.
• Acute care delivery requires robust frameworks to ensure quality and safety.

Purpose of the Study:

• To gather evidence for a new approach to managing acute multiple sclerosis (MS) relapses.
• To investigate the clinical governance implications of cross-boundary collaboration in healthcare delivery.
• To provide useful frameworks for delivering acute care in community settings and designing collaborative research.

Main Methods:

• A trial was designed by the MS team at the National Hospital for Neurology and Neurosurgery.
• Collaboration involved the voluntary and commercial sectors.
• Intravenous steroids were administered in a home environment for acute MS relapse management.

Main Results:

• The study successfully gathered evidence for home-based acute MS relapse management.
• Key clinical governance processes for cross-boundary working were established.
• The study provided insights into collaborative research trial design.

Conclusions:

• Delivering acute care outside hospitals necessitates strong clinical governance.
• Cross-boundary collaboration between healthcare providers, voluntary, and commercial sectors is feasible.
• The frameworks developed can guide future community-based acute care initiatives and research.